logo
welcome
Fortune

Fortune

Health

Health

Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span

Fortune
Summary
Nutrition label

75% Informative

Retro Biosciences has announced a $1 billion round of funding toward its goal of developing therapies that reverse age-related disease.

Some of the investment will come from OpenAI CEO Sam Altman , who also provided the initial $180 million to seed the startup.

The fundraising is being led by Italian financier Sandro Salsano .